With the progression of the Delta variant and the data from the vaccination of young Americans, the French Pediatric Society has changed its position with regard to the vaccination of 12-17 year olds. If only children at risk or in contact with immunocompromised people were to be vaccinated initially, it now considers that the expected benefit outweighs the risks.
EXTRACT - Vaccination of adolescents: the benefit outweighs the risks, according to the French Pediatric Society
2021-07-19T08:38:46.154Z
With the progression of the Delta variant and the data from the vaccination of young Americans, the French Pediatric Society has changed its position in relation to the vaccination of 12-17 year olds. & Nbsp; If only children at risk or in contact with people immunocompromised should be vaccinated first, she now considers that the expected benefit outweighs the risks.
Source: europe1